Exagen to Announce Second Quarter 2024 Results on August 5, 2024

Rhea-AI Summary

Exagen Inc. (Nasdaq: XGN), a leading autoimmune testing provider, has announced it will release its second quarter 2024 financial results on August 5, 2024, before the market opens. The company will host a conference call at 8:30 AM ET on the same day, featuring President and CEO John Aballi and CFO Kamal Adawi.

Interested parties can join the call by dialing (201) 389-0918 (U.S.) or (877) 407-0890 (international). A webcast link will be available on Exagen's investor relations website. A replay of the call will be accessible until August 19, 2024, via phone and webcast recording.

CARLSBAD, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter ended June 30, 2024, before the market opens on Monday, August 5, 2024. John Aballi, Exagen’s President and Chief Executive Officer, and Kamal Adawi, Chief Financial Officer, will host a conference call to review the Company’s results at 8:30 AM ET (5:30 AM PT).

Interested parties may access the conference call by dialing (201) 389-0918 (U.S.) or (877) 407-0890 (international). Participants wishing to access the call via webcast should use the link posted on the Exagen investor relations website at investors.exagen.com.

A replay of the conference call will be available until Monday, August 19, 2024, at 11:59 PM ET (8:59 PM PT). Interested parties may access the replay of the conference call by dialing (201) 612-7415 (U.S.) or (877) 660-6853 (international) using passcode 13747595. Additionally, a recording of the webcast will be available using the link on the Exagen investor relations website approximately one hour after the call concludes.

About Exagen Inc.

Exagen is a leading provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision making with the goal of improving patients’ clinical outcomes. Exagen is located in San Diego County, California.

For more information, please visit Exagen.com or follow @ExagenInc on X (formerly known as Twitter).

Contact:
Ryan Douglas
Exagen Inc.
ir@exagen.com
760.560.1525

FAQ

When will Exagen (XGN) release its Q2 2024 financial results?

Exagen (XGN) will release its second quarter 2024 financial results on August 5, 2024, before the market opens.

What time is Exagen's (XGN) Q2 2024 earnings conference call?

Exagen's (XGN) Q2 2024 earnings conference call is scheduled for 8:30 AM ET (5:30 AM PT) on August 5, 2024.

How can investors access Exagen's (XGN) Q2 2024 earnings call?

Investors can access Exagen's (XGN) Q2 2024 earnings call by dialing (201) 389-0918 (U.S.) or (877) 407-0890 (international), or via webcast on the company's investor relations website.

Until when will the replay of Exagen's (XGN) Q2 2024 earnings call be available?

The replay of Exagen's (XGN) Q2 2024 earnings call will be available until Monday, August 19, 2024, at 11:59 PM ET (8:59 PM PT).